Last updated: September 8, 2022
Sponsor: Inonu University
Overall Status: Completed
Phase
N/A
Condition
Stroke
Cerebral Ischemia
Treatment
N/AClinical Study ID
NCT05538468
2019/3-22
Ages 25-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- individuals who were diagnosed with hemiplegia or hemiparesis after SVO,
- at least 6 months after SVO,
- who were Level 2 and above according to the Functional Ambulation Classification,
- who wanted to participate in the study voluntarily
Exclusion
Exclusion Criteria:
- Anyone with a major neurological or rheumatological pathology (polyneuropathy,parkinson's, multiple sclerosis, rheumatoid arthritis, etc.)
- Affecting the musculoskeletal system other than stroke
- Who does not allow mental evaluation, cannot fill in the scales,
- is illiterate, has aphasia, has a history of falling,
- have any cardiac problems,
- amputation in the lower extremities,
- those with active malignancy and related chemo/radiotherapy,
- the presence of accompanying lower motor neuron or peripheral nerve lesion,
- any musculoskeletal problem and related pain (lumbar disc herniation, meniscus, etc.),
- ındividuals with shoulder subluxation, shoulder-hand syndrome
- those who refused to participate in the study
Study Design
Total Participants: 30
Study Start date:
February 10, 2019
Estimated Completion Date:
July 30, 2019
Study Description
Connect with a study center
Inonu University
Malatya,
TurkeySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.